Images List Premium Download Classic

Antibodies

Antibodies-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Opioid detection
Randox Laboratories Limited
June 22, 2017 - N°20170176476

An immunoassay method is described which detects o-desmethyltramadol only. This enables an assay of high sensitivity and specificity avoiding false positive results. The unique antibodies incorporated in the immunoassay method can be combined with antibodies which detect mitragynine to provide an assay which increases the possibility of detecting the commonly found drug combination of o-desmethyltramadol and mitragynine.
Antibodies to quetiapine and use thereof
Janssen Pharmaceutica Nv
June 22, 2017 - N°20170176474

Disclosed is an antibody or a binding fragment thereof which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody or the fragment thereof can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in ...
Antibodies to risperidone and use thereof
Janssen Pharmaceutica Nv
June 22, 2017 - N°20170176473

Disclosed is an antibody or a binding fragment thereof that binds to risperidone, which can be used to detect risperidone in a sample such as in a competitive immunoassay method. The antibody or fragment thereof can be used in a lateral flow assay device for point-of-care detection of risperidone, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a ...
Antibodies Patent Pack
Download 1876+ patent application PDFs
Antibodies Patent Applications
Download 1876+ Antibodies-related PDFs
For professional research & prior art discovery
inventor
  • 1876+ full patent PDF documents of Antibodies-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
Bio-rad Laboratories, Inc.
June 22, 2017 - N°20170176462

Hemoglobin, its variants, and glycated forms of each are determined individually in a multiplex assay that permits correction of the measured level of hba1c to account for glycated variants and other factors related to the inclusion of the variants in the sample. New antibodies that are particularly well adapted to the multiplex assay are also provided.
Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders
Immco Diagnostics, Inc.
June 22, 2017 - N°20170176454

Provided are compositions that contain mammalian cells for use in detecting antibodies. The mammalian cells are modified such that they do not contain ledgf protein. The mammalian cells are immobilized on a solid substrate. The compositions can also contain mammalian cells that contain the ledgf protein. Methods for using the cell compositions in diagnostic approaches are included, as are kits ...
Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor receptor (vegfr)
Celltrend Gmbh
June 22, 2017 - N°20170176444

The present invention relates to a method for diagnosis of a cancer, comprising the steps of (i) determining the level of antibodies against vascular endothelial growth factor receptor (vegfr) in a sample from a subject to be diagnosed, (ii) comparing the determined level in the sample to a control level derived from subjects without cancer; wherein a decreased level in ...
Antibodies Patent Pack
Download 1876+ patent application PDFs
Antibodies Patent Applications
Download 1876+ Antibodies-related PDFs
For professional research & prior art discovery
inventor
  • 1876+ full patent PDF documents of Antibodies-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Assays for detecting neutralizing autoantibodies to biologic therapy
Nestec S.a.
June 22, 2017 - N°20170176433

The present invention provides assays for detecting and measuring the presence or level of neutralizing and non-neutralizing autoantibodies to biologics such as anti-tnfα drug therapeutics in a sample. The present invention is useful for monitoring the formation of neutralizing and/or non-neutralizing anti-drug antibodies over time while a subject is on biologic therapy. The present invention is also ...
Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof
Siemens Healthcare Diagnostics Inc.
June 22, 2017 - N°20170176419

A chemiluminescent detection system, as well as kits and microfluidics devices containing same, are disclosed. Methods of using the system, kits, and devices are also disclosed. The first, second, and third antibodies or binding fragments thereof may be provided in any form that allows these antibodies/binding fragments to function in accordance with the presently disclosed and claimed inventive concept(...
Pore-forming protein conjugate compositions and methods
The Trustees Of Columbia University In The City Of New York
June 22, 2017 - N°20170175183

The present disclosure relates to compositions and methods based on a fast, efficient chemical reaction for conjugating a pore-forming protein, such as α-hemolysin, to a biomolecule, such as antibodies, receptors, and enzymes, such as dna polymerase, and the use of such pore-forming protein conjugates in nanopore devices and methods.
Pesticidal genes and methods of use
Agbiome, Inc.
June 22, 2017 - N°20170175134

Compositions having pesticidal activity and methods for their use are provided. Compositions include isolated and recombinant polypeptides having pesticidal activity, recombinant and synthetic nucleic acid molecules encoding the polypeptides, dna constructs and vectors comprising the nucleic acid molecules, host cells comprising the vectors, and antibodies to the polypeptides. Polynucleotide sequences encoding the polypeptides can be used in dna constructs or ...
Inhibition of bruton's tyrosine kinase (btk) in the lung to treat severe lung inflammation and ...
Board Of Regents, The University Of Texas System
June 22, 2017 - N°20170175125

Bruton's tyrosine kinase (btk) plays an important role in the pathophysiology of local inflammation in acute lung injury (ali)/acute respiratory distress syndrome (ards). A unique two hit model of ali induced by lipopolysaccharide (lps)/immune complex (ic)—was developed, along with viral-induced ali caused by influenza virus and copd caused by second hand smoke. Two types or therapeutics (...
Rna-based compositions and adjuvants for prophylactic and therapeutic treatment
University Of Kentucky Research Foundation
June 22, 2017 - N°20170175122

The present invention is directed towards an artificial rna nanostructure comprising multiple external strands of rna, each external strand comprising about 40-50 nucleotides; one internal strand of rna comprising more than about 50 nucleotides; the internal strands and external strands assembled to form a triangle nanostructure, a square nanostructure, or a polygon nanostructure and a prna three-way junction (3wj) motif at ...
Antibodies Patent Pack
Download 1876+ patent application PDFs
Antibodies Patent Applications
Download 1876+ Antibodies-related PDFs
For professional research & prior art discovery
inventor
  • 1876+ full patent PDF documents of Antibodies-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Anti-tie2 antibodies and uses thereof
Regeneron Pharmaceuticals, Inc.
June 22, 2017 - N°20170174789

The present invention provides antibodies that bind to tie2 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human tie2 and block the interaction between tie2 and one or more tie2 ligands such as angiopoietin 1 (ang1), angiopoietin 2 (ang2), angiopoietin 3 (ang3) and/or angiopoietin 4 (ang4). The antibodies of the ...
Anti-her3 antibodies and uses thereof
Roche Glycart Ag
June 22, 2017 - N°20170174784

The present invention relates to antibodies binding to human her3 (anti-her3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Anti-her2 antibodies and immunoconjugates
Genentech, Inc.
June 22, 2017 - N°20170174782

The invention provides anti-her2 antibodies and immunoconjugates and methods of using the same.
Bispecific anti-cd20/anti-cd3 antibodies to treat acute lymphoblastic leukemia
Regeneron Pharmaceuticals, Inc.
June 22, 2017 - N°20170174781

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of acute lymphoblastic leukemia. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a bispecific antibody that specifically binds to cd20 and cd3.
Combination therapies with anti-cd38 antibodies
Janssen Biotech, Inc.
June 22, 2017 - N°20170174780

The present invention relates to combination therapies with anti-cd38 antibodies.
Combination of anti-pd-1 antibodies and anti-cd20/anti-cd3 antibodies to treat cancer
Regeneron Pharmaceuticals, Inc.
June 22, 2017 - N°20170174779

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e. G., a b-cell cancer such as hodgkin's lymphoma or acute lymphoblastic leukemia). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to programmed death 1 (...
Ph dependent antibodies targeting the transferrin receptor
Wisconsin Alumni Research Foundation
June 22, 2017 - N°20170174778

A ph-dependent antibody that binds an antigen with high affinity at a first ph and rapidly dissociates at a second ph, wherein the antigen is a transferrin receptor (tfr), wherein the association at the second ph/the first ph is less than 20%, and wherein the ph-dependent antibody comprises at least two consecutive histidine residues at a single complementarity determining region (...
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
Wisconsin Alumni Research Foundation
June 22, 2017 - N°20170174777

Alzheimer's and parkinson's disease comorbidity, and pure autonomic failure, as well as multiple system atrophy (msa).
Loading